Helen Collins

5.5k total citations · 1 hit paper
78 papers, 4.0k citations indexed

About

Helen Collins is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Helen Collins has authored 78 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 17 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Helen Collins's work include Hemoglobinopathies and Related Disorders (8 papers), Tuberculosis Research and Epidemiology (7 papers) and Iron Metabolism and Disorders (7 papers). Helen Collins is often cited by papers focused on Hemoglobinopathies and Related Disorders (8 papers), Tuberculosis Research and Epidemiology (7 papers) and Iron Metabolism and Disorders (7 papers). Helen Collins collaborates with scholars based in United States, United Kingdom and Germany. Helen Collins's co-authors include Stefan H. E. Kaufmann, Ulrich E. Schaible, David G. Russell, Sheila Sturgill-Koszycki, Prasanta Chakraborty, Richard D. Allen, Stephen L. Gluck, Paul H. Schlesinger, Pryce L. Haddix and John Heuser and has published in prestigious journals such as Science, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Helen Collins

74 papers receiving 3.9k citations

Hit Papers

Lack of Acidification in Mycobacterium Phagosomes Produce... 1994 2026 2004 2015 1994 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lack of Acidification in Mycobacterium Phagosomes Produced by Exclusion of the Vesicular Proton-ATPase
    1994 1.0k citations Helen Collins, David G. Russell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Collins United States 33 1.4k 1.4k 1.3k 888 380 78 4.0k
Hkw Law Hong Kong 38 1.3k 0.9× 765 0.6× 1.4k 1.1× 1.3k 1.5× 178 0.5× 119 4.9k
Hisami Ikeda Japan 38 681 0.5× 739 0.5× 1.6k 1.3× 1.8k 2.0× 971 2.6× 170 5.9k
Peter M. Keller Switzerland 31 888 0.6× 1.0k 0.7× 509 0.4× 1.8k 2.1× 303 0.8× 146 4.4k
Yi Wang China 37 1.2k 0.8× 709 0.5× 1.1k 0.9× 2.5k 2.8× 155 0.4× 263 5.7k
Victoria H. Freedman United States 23 1.3k 0.9× 1.1k 0.8× 1.0k 0.8× 1.5k 1.7× 299 0.8× 40 4.2k
Tasuke Konno Japan 24 841 0.6× 544 0.4× 1.3k 1.0× 1.5k 1.7× 359 0.9× 128 4.4k
John L. Ryan United States 33 684 0.5× 952 0.7× 2.5k 1.9× 1.6k 1.8× 132 0.3× 92 5.6k
Dermot Cox Ireland 38 892 0.6× 933 0.7× 782 0.6× 1.1k 1.3× 1.4k 3.6× 99 5.5k
Jean Pieters Switzerland 44 2.2k 1.6× 1.9k 1.4× 3.5k 2.8× 2.9k 3.3× 267 0.7× 109 8.1k
Julián Pardo Spain 40 681 0.5× 744 0.5× 2.3k 1.8× 2.0k 2.2× 293 0.8× 147 5.5k

Countries citing papers authored by Helen Collins

Since Specialization
Citations

This map shows the geographic impact of Helen Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Collins more than expected).

Fields of papers citing papers by Helen Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Collins. The network helps show where Helen Collins may publish in the future.

Co-authorship network of co-authors of Helen Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Collins. A scholar is included among the top collaborators of Helen Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Collins. Helen Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wainberg, Zev A., Peter C. Enzinger, Yoon‐Koo Kang, et al.. (2021). Randomized double-blind placebo-controlled phase 2 study of bemarituzumab combined with modified FOLFOX6 (mFOLFOX6) in first-line (1L) treatment of advanced gastric/gastroesophageal junction adenocarcinoma (FIGHT).. Journal of Clinical Oncology. 39(3_suppl). 160–160. 63 indexed citations
3.
Xiang, Hong, Lucy Liu, Yuying Gao, Ago Ahene, & Helen Collins. (2021). Covariate effects and population pharmacokinetic analysis of the anti-FGFR2b antibody bemarituzumab in patients from phase 1 to phase 2 trials. Cancer Chemotherapy and Pharmacology. 88(5). 899–910. 2 indexed citations
4.
Spina, Domenico, Yanira Riffo‐Vasquez, Rafael T. M. de Rosales, et al.. (2015). In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery. Journal of Controlled Release. 210. 1–9. 81 indexed citations
5.
Arellano, Jorge, Brett Hauber, Ateesha F. Mohamed, et al.. (2015). Physicians’ Preferences for Bone Metastases Drug Therapy in the United States. Value in Health. 18(1). 78–83. 22 indexed citations
6.
Mohamed, Ateesha F., Yi Qian, Brett Hauber, et al.. (2013). Nurses’ Preferences for Bone Metastases Treatments in the United States. Value in Health. 16(7). A430–A430. 1 indexed citations
7.
Pirker, Robert, et al.. (2012). Hemoglobin decline in cancer patients receiving chemotherapy without an erythropoiesis-stimulating agent. Supportive Care in Cancer. 21(4). 987–992. 14 indexed citations
8.
Kumar, Abhinav, et al.. (2012). The delivered dose: Applying particokinetics to in vitro investigations of nanoparticle internalization by macrophages. Journal of Controlled Release. 162(2). 259–266. 61 indexed citations
9.
Mowat, Fionna, Michael A. Kelsh, Jason C. Legg, et al.. (2011). PCN129 USE OF ELECTRONIC MEDICAL RECORDS (EMR) FOR ONCOLOGY OUTCOMES RESEARCH: ASSESSING THE COMPARABILITY OF EMR INFORMATION TO PATIENT REGISTRY AND HEALTH CLAIMS DATA. Value in Health. 14(3). A178–A178. 5 indexed citations
10.
Fakih, Sarah, Maria Podinovskaia, Xiaole Kong, et al.. (2008). Monitoring intracellular labile iron pools: A novel fluorescent iron(iii) sensor as a potential non-invasive diagnosis tool. Journal of Pharmaceutical Sciences. 98(6). 2212–2226. 38 indexed citations
11.
Collins, Helen. (2003). The role of iron in infections with intracellular bacteria. Immunology Letters. 85(2). 193–195. 76 indexed citations
12.
Fischer, Karsten, Helen Collins, Masaru Taniguchi, Stefan H. E. Kaufmann, & Ulrich E. Schaible. (2002). IL-4 and T Cells Are Required for the Generation of IgG1 Isotype Antibodies Against Cardiolipin. The Journal of Immunology. 168(6). 2689–2694. 21 indexed citations
13.
Collins, Helen, Stefan H. E. Kaufmann, & Ulrich E. Schaible. (2002). Iron Chelation Via Deferoxamine Exacerbates Experimental Salmonellosis Via Inhibition of the Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Dependent Respiratory Burst. The Journal of Immunology. 168(7). 3458–3463. 55 indexed citations
14.
Collins, Helen & Stefan H. E. Kaufmann. (2001). The many faces of host responses to tuberculosis. Immunology. 103(1). 1–9. 117 indexed citations
15.
Rolph, Michael S., Bärbel Raupach, Helen Collins, et al.. (2001). MHC class Ia-restricted T cells partially account for β2-microglobulin-dependent resistance toMycobacterium tuberculosis. European Journal of Immunology. 31(6). 1944–1949. 66 indexed citations
16.
Collins, Helen & Stefan H. E. Kaufmann. (2001). Prospects for better tuberculosis vaccines. The Lancet Infectious Diseases. 1(1). 21–28. 41 indexed citations
17.
Schaible, Ulrich E., Kristine Hagens, Karsten Fischer, Helen Collins, & Stefan H. E. Kaufmann. (2000). Intersection of Group I CD1 Molecules and Mycobacteria in Different Intracellular Compartments of Dendritic Cells. The Journal of Immunology. 164(9). 4843–4852. 95 indexed citations
18.
Collins, Helen, I Flesch, Masashi Emoto, & Stefan H. E. Kaufmann. (1998). Interleukin-4 Production in Response to Infection with Intracellular Bacteria. Advances in experimental medicine and biology. 452. 75–83. 4 indexed citations
19.
Collins, Helen, et al.. (1997). IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. The Journal of Immunology. 158(1). 330–337. 135 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hkw Law Breakdown of academic impact, for papers by Hisami Ikeda Breakdown of academic impact, for papers by Peter M. Keller Breakdown of academic impact, for papers by Yi Wang Breakdown of academic impact, for papers by Victoria H. Freedman Breakdown of academic impact, for papers by Tasuke Konno Breakdown of academic impact, for papers by John L. Ryan Breakdown of academic impact, for papers by Dermot Cox Breakdown of academic impact, for papers by Jean Pieters Breakdown of academic impact, for papers by Julián Pardo
Rankless by CCL
2026